112 related articles for article (PubMed ID: 9507079)
1. Understanding the molecular mechanism of viral resistance to peptidomimetic inhibitors of ribonucleotide reductase.
White PW
Biochim Biophys Acta; 1998 Jan; 1382(1):102-10. PubMed ID: 9507079
[TBL] [Abstract][Full Text] [Related]
2. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.
Bonneau AM; Kibler P; White P; Bousquet C; Dansereau N; Cordingley MG
J Virol; 1996 Feb; 70(2):787-93. PubMed ID: 8551616
[TBL] [Abstract][Full Text] [Related]
3. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Grenier L; Llinas-Brunet M; Plante R
J Med Chem; 1995 Sep; 38(18):3617-23. PubMed ID: 7658449
[TBL] [Abstract][Full Text] [Related]
4. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
Liuzzi M; Déziel R; Moss N; Beaulieu P; Bonneau AM; Bousquet C; Chafouleas JG; Garneau M; Jaramillo J; Krogsrud RL
Nature; 1994 Dec; 372(6507):695-8. PubMed ID: 7990963
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
[TBL] [Abstract][Full Text] [Related]
6. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
[TBL] [Abstract][Full Text] [Related]
7. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
Lawetz C; Liuzzi M
Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
[TBL] [Abstract][Full Text] [Related]
8. Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.
Sun Y; Conner J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):97-104. PubMed ID: 10727407
[TBL] [Abstract][Full Text] [Related]
9. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
Krogsrud RL; Welchner E; Scouten E; Liuzzi M
Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.
Brandt CR; Spencer B; Imesch P; Garneau M; Déziel R
Antimicrob Agents Chemother; 1996 May; 40(5):1078-84. PubMed ID: 8723444
[TBL] [Abstract][Full Text] [Related]
11. Oligopeptide inhibition of class I ribonucleotide reductases.
Cooperman BS
Biopolymers; 2003; 71(2):117-31. PubMed ID: 12767114
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
[TBL] [Abstract][Full Text] [Related]
13. Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.
Lamarche N; Gaudreau P; Massie B; Langelier Y
Anal Biochem; 1994 Aug; 220(2):315-20. PubMed ID: 7978273
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase inhibitors as anti-herpes agents.
Wnuk SF; Robins MJ
Antiviral Res; 2006 Sep; 71(2-3):122-6. PubMed ID: 16621038
[TBL] [Abstract][Full Text] [Related]
15. Identification of structural domains within the large subunit of herpes simplex virus ribonucleotide reductase.
Conner J; Cross A; Murray J; Marsden H
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3327-35. PubMed ID: 7996127
[TBL] [Abstract][Full Text] [Related]
16. Intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase subunits during infection of cultured cells.
Conner J; Murray J; Cross A; Clements JB; Marsden HS
Virology; 1995 Nov; 213(2):615-23. PubMed ID: 7491785
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.
Petrowsky H; Roberts GD; Kooby DA; Burt BM; Bennett JJ; Delman KA; Stanziale SF; Delohery TM; Tong WP; Federoff HJ; Fong Y
J Virol; 2001 Aug; 75(15):7050-8. PubMed ID: 11435585
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus type 1 ribonucleotide reductase by substituted tetrapeptide derivatives.
Moss N; Déziel R; Adams J; Aubry N; Bailey M; Baillet M; Beaulieu P; DiMaio J; Duceppe JS; Ferland JM
J Med Chem; 1993 Oct; 36(20):3005-9. PubMed ID: 8411018
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 1 ribonucleotide reductase large subunit: regions of the protein essential for subunit interaction and dimerization.
Conner J; Furlong J; Murray J; Meighan M; Cross A; Marsden H; Clements JB
Biochemistry; 1993 Dec; 32(49):13673-80. PubMed ID: 8257701
[TBL] [Abstract][Full Text] [Related]
20. Ureido-based peptidomimetic inhibitor of herpes simplex virus ribonucleotide reductase: an investigation of inhibitor bioactive conformation.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Guse I; Llinàs-Brunet M; Plante R; Plamondon L; Wernic D; Déziel R
J Med Chem; 1996 May; 39(11):2178-87. PubMed ID: 8667361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
